GP2013 in Japanese Patients With CD20 Positive Low Tumor Burden Indolent B-cell Non-Hodgkin's Lymphoma

NCT01933516 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Indolent B-cell Non-Hodgkin's Lymphoma

Interventions

DRUG: GP2013

Sponsor

Sandoz

Collaborators

[object Object]